J Haensler

Summary

Affiliation: Sanofi Pasteur

Publications

  1. doi request reprint Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion
    Jean Haensler
    Sanofi Pasteur R and D, Marcy l Etoile, France Electronic address
    Int J Pharm 486:99-111. 2015
  2. doi request reprint [Introduction to novel vaccine adjuvants and their role in influenza vaccination]
    J Haensler
    Discovery R and D, Sanofi Pasteur, Campus Merieux, 1541, avenue Marcel Mérieux, 69280 Marcy l Etoile, France
    Ann Pharm Fr 71:104-8. 2013

Detail Information

Publications2

  1. doi request reprint Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion
    Jean Haensler
    Sanofi Pasteur R and D, Marcy l Etoile, France Electronic address
    Int J Pharm 486:99-111. 2015
    ....
  2. doi request reprint [Introduction to novel vaccine adjuvants and their role in influenza vaccination]
    J Haensler
    Discovery R and D, Sanofi Pasteur, Campus Merieux, 1541, avenue Marcel Mérieux, 69280 Marcy l Etoile, France
    Ann Pharm Fr 71:104-8. 2013
    ..Nevertheless, the development of new adjuvants remains challenging in terms of quality and safety assurance and in terms of clinical and industrial development costs...